Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial
Wagner, Monika, PhD, Lindgren, Peter, PhD, Merikle, Elizabeth, PhD, Goetghebeur, Mireille, PhD, Jönsson, Bengt, PhD
Published in Canadian journal of cardiology (01.11.2009)
Published in Canadian journal of cardiology (01.11.2009)
Get full text
Journal Article